Tsapepas DS - Search Results

1

Clostridium difficile infection, a descriptive analysis of solid organ transplant recipients at a single center.

Tsapepas DS, Martin ST, Miao J, Shah SA, Scheffert J, Fester K, Ma K, Lat A, Egan R, McKeen JT. Tsapepas DS, et al. Diagn Microbiol Infect Dis. 2015 Apr;81(4):299-304. doi: 10.1016/j.diagmicrobio.2014.11.018. Epub 2014 Dec 3. Diagn Microbiol Infect Dis. 2015. PMID: 25586932

2

Enhancements in healthcare information technology systems: customizing vendor-supplied clinical decision support for a high-risk patient population.

Tiwari R, Tsapepas DS, Powell JT, Martin ST. Tiwari R, et al. Among authors: tsapepas ds. J Am Med Inform Assoc. 2013 Mar-Apr;20(2):377-80. doi: 10.1136/amiajnl-2012-001080. Epub 2012 Jul 19. J Am Med Inform Assoc. 2013. PMID: 22813760 Free PMC article.

3

Managing renal transplant ischemia reperfusion injury: novel therapies in the pipeline.

Powell JT, Tsapepas DS, Martin ST, Hardy MA, Ratner LE. Powell JT, et al. Among authors: tsapepas ds. Clin Transplant. 2013 Jul-Aug;27(4):484-91. doi: 10.1111/ctr.12121. Epub 2013 Apr 25. Clin Transplant. 2013. PMID: 23614480 Review.

4

Risk factors associated with Clostridium difficile infection after kidney and pancreas transplantation.

Shah SA, Tsapepas DS, Kubin CJ, Martin ST, Mohan S, Ratner LE, Pereira M, Kapur S, Dadhania D, Walker-McDermott JK. Shah SA, et al. Among authors: tsapepas ds. Transpl Infect Dis. 2013 Oct;15(5):502-9. doi: 10.1111/tid.12113. Epub 2013 Jul 25. Transpl Infect Dis. 2013. PMID: 23890202

5

An update to managing renal transplant ischemia reperfusion injury: novel therapies in the pipeline.

Tsapepas DS, Powell JT, Martin ST, Hardy MA, Ratner LE. Tsapepas DS, et al. Clin Transplant. 2013 Sep-Oct;27(5):647-8. doi: 10.1111/ctr.12204. Epub 2013 Aug 8. Clin Transplant. 2013. PMID: 23924169 No abstract available.

6

Risk of posttransplant lymphoproliferative disorder associated with use of belatacept.

Martin ST, Powell JT, Patel M, Tsapepas D. Martin ST, et al. Am J Health Syst Pharm. 2013 Nov 15;70(22):1977-83. doi: 10.2146/ajhp120770. Am J Health Syst Pharm. 2013. PMID: 24173007 Review.

7

Risk evaluation and mitigation strategy programs in solid organ transplantation: the promises of information technology.

Tsapepas DS, McKeen JT, Martin ST, Walker-McDermott JK, Yang A, Hirsch J, Mohan S, Tiwari R. Tsapepas DS, et al. J Am Med Inform Assoc. 2014 Oct;21(e2):e358-62. doi: 10.1136/amiajnl-2013-002446. Epub 2014 Feb 26. J Am Med Inform Assoc. 2014. PMID: 24573422 Free PMC article.

8

Acyclovir versus valganciclovir for preventing cytomegalovirus infection in intermediate-risk liver transplant recipients.

McKeen JT, Tsapepas DS, Li H, Anamisis A, Martin ST. McKeen JT, et al. Among authors: tsapepas ds. Prog Transplant. 2015 Mar;25(1):39-44. doi: 10.7182/pit2015558. Prog Transplant. 2015. PMID: 25758799

9

Direct oral anticoagulant considerations in solid organ transplantation: A review.

Salerno DM, Tsapepas D, Papachristos A, Chang JH, Martin S, Hardy MA, McKeen J. Salerno DM, et al. Clin Transplant. 2017 Jan;31(1):10.1111/ctr.12873. doi: 10.1111/ctr.12873. Epub 2016 Dec 28. Clin Transplant. 2017. PMID: 27859621 Free PMC article. Review.

10

Outcomes for potential kidney transplant recipients offered public health service increased risk kidneys: A single-center experience.

Fernandez HE, Chiles MC, Pereira M, Husain SA, Miko B, Baral P, Dale LA, Patel S, Runge B, Tsapepas D, Sandoval PR, Ratner LE, Cohen DJ, Mohan S. Fernandez HE, et al. Clin Transplant. 2018 Dec;32(12):e13427. doi: 10.1111/ctr.13427. Epub 2018 Nov 8. Clin Transplant. 2018. PMID: 30329179 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73 results

Search Page

Filters